The MOTS (Medication Overuse Treatment Strategy) Trial

Inclusion Criteria * Adults, at least 21 years of age * Chronic Migraine - diagnosed according to ICHD3beta criteria * Medication Overuse - diagnosed according to ICHD3beta criteria * Willingness to be randomized to either of the two treatment arms * Willingness to maintain a headache diary * Plan for follow-up care with the clinician * No changes to migraine prophylactic therapy within the 4 weeks prior to randomization. Exclusion Criteria * Younger than 21 years of age * Headache diagnoses other than chronic migraine with medication overuse; episodic tension-type headache on 3 or fewer days per month is allowed * Not willing to be randomized to either of the treatment arms * Not willing to maintain a daily headache diary * Not planning on follow-up care with the clinician * In the opinion of the clinician, randomization to either treatment arm would be considered unsafe (ex: pregnancy, immediate discontinuation * Prisoners * Diminished decision-making capacity which in the investigator's opinion would interfere with the person's ability to provide informed consent and complete study procedures.